Melissa Summers, MD
Sports Medicine · Cincinnati, OHNPI 1366820854
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (44.0%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Arthrex at 49.6% of the total. Reporting peaked in 2021 at $39,034 and has fallen 93.6% since, to $2,484 in 2025. Among sports medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 163 payments — averaging $546.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$44K
- Smith+Nephew$31K
- Legacy Ortho LLC$9K
- DJO, LLC$3K
- Stryker$2K
- Johnson & Johnson$133
- plus $133 from 5 others
What the payments were for
- Grants$36,24941%
- Travel & lodging$9,35311%
- Food & beverage$4,2615%
- Education$39,17144%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 92 | $44,125 |
| Smith+Nephew | 12 | $31,117 |
| Legacy Ortho LLC | 26 | $8,975 |
| DJO, LLC | 2 | $2,917 |
| Stryker | 24 | $1,635 |
| Johnson & Johnson | 2 | $133 |
| BREG, Inc | 1 | $50 |
| Impactortho, Inc. | 1 | $23 |
| Vericel Corporation | 1 | $21 |
| Vertex | 1 | $21 |
| Bioventus LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$89,035 in reported general payments places this provider in the 95th percentile of 278 sports medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 98 | $468 |
| Gabapentin | 30 | $211 |
| Methocarbamol | 30 | $210 |
| Methylprednisolone | 28 | $183 |
| Ibuprofen | 26 | $158 |
| Ondansetron Hcl | 21 | $128 |
| Cyclobenzaprine Hcl | 11 | $91 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $78 |
| Tramadol Hcl | 17 | $64 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Cincinnati
- Vincent SammarcoCincinnati$361K
- Brian GraweCincinnati$50K
- Timothy KremchekCincinnati$28K
- George MaticCincinnati$22K
- Michelle AndrewsCincinnati$22K
- Ian RiceCincinnati$14K
- Samir SharrakCincinnati$12K
- David FlaniganColumbus$915K
- Thomas EllisDublin$427K
- Paul SaluanCleveland$367K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.